A multi-center study of fidaxomicin use for Clostridium difficile infection

PURPOSE: Fidaxomicin use in real-world clinical practice, especially for severe Clostridium difficile infection (CDI), is mainly based on single-center observational studies. The purpose of this pharmacoepidemiology study was to assess outcomes of patients given fidaxomicin based on episode number a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Dhara N., Chan, Fay S., Kachru, Nandita, Garcia, Krutina P., Balcer, Holly E., Dyer, April P., Emanuel, John E., Jordan, Michelle D., Lusardi, Katherine T., Naymick, Geri, Polisetty, Radhika S., Sieman, Lanny, Tyler, Ashley M., Johnson, Michael L., Garey, Kevin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970984/
https://www.ncbi.nlm.nih.gov/pubmed/27536508
http://dx.doi.org/10.1186/s40064-016-2825-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970984/
https://www.ncbi.nlm.nih.gov/pubmed/27536508
http://dx.doi.org/10.1186/s40064-016-2825-x

Ejemplares similares